HRT Financial’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-29,173
| Closed | -$48K | – | 2521 |
|
|
2024
Q4 | $48K | Sell |
29,173
-179,971
| -86% | -$296K | ﹤0.01% | 1900 |
|
|
2024
Q3 | $732K | Buy |
209,144
+150,118
| +254% | +$525K | ﹤0.01% | 1295 |
|
|
2024
Q2 | $193K | Buy |
+59,026
| New | +$193K | ﹤0.01% | 1502 |
|
|
2024
Q1 | – | Sell |
-395,753
| Closed | -$1.48M | – | 2398 |
|
|
2023
Q4 | $1.48M | Sell |
395,753
-277,537
| -41% | -$1.04M | 0.01% | 745 |
|
|
2023
Q3 | $1.43M | Buy |
673,290
+411,679
| +157% | +$873K | 0.01% | 722 |
|
|
2023
Q2 | $1.25M | Buy |
+261,611
| New | +$1.25M | 0.01% | 762 |
|
|
2023
Q1 | – | Sell |
-37,915
| Closed | -$382K | – | 2498 |
|
|
2022
Q4 | $382K | Sell |
37,915
-68,210
| -64% | -$687K | 0.01% | 1463 |
|
|
2022
Q3 | $2.38M | Buy |
+106,125
| New | +$2.38M | 0.03% | 524 |
|
|
2021
Q4 | – | Sell |
-56,876
| Closed | -$3.37M | – | 3128 |
|
|
2021
Q3 | $3.37M | Sell |
56,876
-57,067
| -50% | -$3.38M | 0.02% | 430 |
|
|
2021
Q2 | $9.89M | Buy |
+113,943
| New | +$9.89M | 0.09% | 178 |
|
|
2021
Q1 | – | Sell |
-16,241
| Closed | -$1.48M | – | 2606 |
|
|
2020
Q4 | $1.48M | Buy |
+16,241
| New | +$1.48M | 0.03% | 410 |
|
|
2019
Q4 | – | Sell |
-28,603
| Closed | -$444K | – | 1244 |
|
|
2019
Q3 | $444K | Buy |
+28,603
| New | +$444K | 0.02% | 640 |
|
|
2018
Q4 | – | Sell |
-35,845
| Closed | -$583K | – | 612 |
|
|
2018
Q3 | $583K | Buy |
+35,845
| New | +$583K | 0.09% | 128 |
|